The positive predictive value for the prostate-specific antigen test for prostate cancer is only 30%. This means that only 30% of people who test positive for elevated levels of prostate-specific antigen actually have prostate cancer. This is an intrinsic problem with testing for prostate-specific antigen not with Theranos' testing.